Protracted manifestations of acute dependence after a single morphine exposure

Psychopharmacology

Volumn 219, Issue 4, 2012, Pages 991-998

  Rothwell, Patrick E ^a,b   Thomas, Mark J ^a   Gewirtz, Jonathan C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Abstinence; Addiction; Anxiety; Aversion; Morphine; Naloxone; Startle; Withdrawal

Indexed keywords

MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVERSION; BEHAVIOR CHANGE; CONDITIONING; CONTROLLED STUDY; EMOTION; LONG TERM EXPOSURE; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84856633649     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2425-y     Document Type: Article

References (74)

1. JU Adams SG Holtzman 1990 Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats J Pharmacol Exp Ther 253 483 489 2338644 1:CAS:528:DyaK3cXktFOrsbs%3D (Pubitemid 20181686)
2. H Araki KY Kawakami C Jin K Suemaru Y Kitamura M Nagata K Futagami K Shibata H Kawasaki Y Gomita 2004 Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats Psychopharmacol (Berl) 171 398 404 10.1007/s00213-003-1595-7 1:CAS:528:DC%2BD2cXmtlGitA%3D%3D (Pubitemid 38200051)
3. G Aston-Jones GC Harris 2004 Brain substrates for increased drug seeking during protracted withdrawal Neuropharmacology 47 Suppl 1 167 179 15464135 10.1016/j.neuropharm.2004.06.020 1:CAS:528:DC%2BD2cXotF2htrY%3D (Pubitemid 39298262)
4. MR Azar BC Jones G Schulteis 2003 Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal Psychopharmacol (Berl) 170 42 50 10.1007/s00213-003-1514-y 1:CAS:528:DC%2BD3sXotVyrtbo%3D (Pubitemid 37372477)
5. TB Baker ME Piper DE McCarthy MR Majeskie MC Fiore 2004 Addiction motivation reformulated: an affective processing model of negative reinforcement Psychol Rev 111 33 51 14756584 10.1037/0033-295X.111.1.33 (Pubitemid 38157073)
6. JL Barr KJ Renner GL Forster 2010 Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus Neuropharmacology 59 395 405 20638943 10.1016/j.neuropharm.2010.05.011 1:CAS:528:DC%2BC3cXht1SqsLbF
7. KE Blatchford K Diamond RF Westbrook GP McNally 2005 Increased vulnerability to stress following opiate exposures: behavioral and autonomic correlates Behav Neurosci 119 1034 1041 16187831 10.1037/0735-7044.119.4.1034 (Pubitemid 41377254)
8. MR Bruchas BB Land JC Lemos C Chavkin 2009 CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior PLoS One 4 e8528 20052275 10.1371/journal.pone.0008528
9. A Cabral RN Ruggiero MJ Nobre ML Brandao VM Castilho 2009 GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine Prog Neuropsychopharmacol Biol Psychiatry 33 334 344 19150477 10.1016/j.pnpbp.2008.12.012 1:CAS:528:DC%2BD1MXit1Wqu78%3D
10. WA Carlezon Jr 2003 Place conditioning to study drug reward and aversion Methods Mol Med 84 243 249 12703329 1:CAS:528:DC%2BD3sXjtlahtL4%3D
11. E Celerier JP Laulin JB Corcuff M Le Moal G Simonnet 2001 Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process J Neurosci 21 4074 4080 11356895 1:CAS:528: DC%2BD3MXjvFGlsb0%3D (Pubitemid 32466499)
12. JA Culpepper-Morgan MJ Kreek 1997 Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal Metabolism 46 130 134 9030816 10.1016/S0026-0495(97)90289-4 1:CAS:528:DyaK2sXht1emsbg%3D (Pubitemid 27078754)
13. M Davis JV Cassella JH Kehne 1988 Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone Psychopharmacol (Berl) 94 14 20 10.1007/BF00735873 1:CAS:528:DyaL1cXmvVymtg%3D%3D (Pubitemid 18009057)
14. M Davis DL Walker L Miles C Grillon 2010 Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety Neuropsychopharmacology 35 105 135 19693004 10.1038/npp.2009.109
15. RM Eisenberg 1982 Further studies on the acute dependence produced by morphine in opiate naive rats Life Sci 31 1531 1540 6890614 10.1016/0024- 3205(82)90043-1 1:CAS:528:DyaL38XlvFaqu7o%3D (Pubitemid 13244533)
16. JM Engelmann AK Radke JC Gewirtz 2009 Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats Psychopharmacol (Berl) 207 13 25 10.1007/s00213-009-1632-2 1:CAS:528: DC%2BD1MXps1Cqt7Y%3D
17. VF Gellert SB Sparber 1977 A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats J Pharmacol Exp Ther 201 44 54 557543 1:CAS:528:DyaE2sXhs1Gns7w%3D (Pubitemid 8085995)
18. EM Glover M Davis 2008 Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone Psychopharmacol (Berl) 198 167 180 10.1007/s00213-008-1112-0 1:CAS:528:DC%2BD1cXlt1Crt7k%3D
19. C Goeldner PE Lutz E Darcq T Halter D Clesse AM Ouagazzal BL Kieffer 2010 Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine Biol Psychiatry 69 3 236 244 20947067 10.1016/j.biopsych.2010.08.021
20. SR Goldberg CR Schuster 1969 Nalorphine: increased sensitivity of monkeys formerly dependent on morphine Science 166 1548 1549 17655059 10.1126/science.166.3912.1548 1:CAS:528:DyaE3cXmsFagsg%3D%3D
21. AC Harris JC Gewirtz 2004 Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety Psychopharmacol (Berl) 171 140 147 10.1007/s00213-003-1573-0 1:CAS:528:DC%2BD3sXhtVSjsLnM (Pubitemid 38134650)
22. AC Harris JC Gewirtz 2005 Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal Psychopharmacol (Berl) 178 353 366 10.1007/s00213-005-2155-0 1:CAS:528:DC%2BD2MXit1amtLk%3D (Pubitemid 40486976)
23. AC Harris SL Hanes JC Gewirtz 2004 Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures Psychopharmacol (Berl) 176 266 273 10.1007/s00213-004-1889-4 1:CAS:528:DC%2BD2cXps1WqtLc%3D (Pubitemid 40012732)
24. AC Harris DM Atkinson DM Aase JC Gewirtz 2006 Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal- potentiated startle Neuroscience 139 1201 1210 16600512 10.1016/j.neuroscience. 2006.01.048 1:CAS:528:DC%2BD28XktVGhur0%3D
25. AC Harris PE Rothwell JC Gewirtz 2008 Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia Psychopharmacol (Berl) 196 649 660 10.1007/s00213-007-0998-2 1:CAS:528:DC%2BD1cXhvFyktb0%3D
26. GA Higgins EM Sellers 1994 Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs Pharmacol Biochem Behav 48 1 8 8029278 10.1016/0091-3057(94)90489-8 1:CAS:528:DyaK2cXivFSjsLo%3D (Pubitemid 24135146)
27. TH Hijzen SW Houtzager RJ Joordens B Olivier JL Slangen 1995 Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs Psychopharmacol (Berl) 118 150 154 10.1007/BF02245833 1:CAS:528:DyaK2MXlt1ygs7Y%3D
28. SG Holtzman 2003 Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence J Pharmacol Exp Ther 304 1033 1041 12604679 10.1124/jpet.102.044875 1:CAS:528:DC%2BD3sXit1eju7c%3D (Pubitemid 36254415)
29. SE Hyman RC Malenka EJ Nestler 2006 Neural mechanisms of addiction: the role of reward-related learning and memory Annu Rev Neurosci 29 565 598 16776597 10.1146/annurev.neuro.29.051605.113009 1:CAS:528:DC%2BD28XosVeit7o%3D (Pubitemid 44476856)
30. C Jin H Araki M Nagata K Suemaru K Shibata H Kawasaki T Hamamura Y Gomita 2004 Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure Psychopharmacol (Berl) 175 428 435 1:CAS:528:DC%2BD2cXotVOht7g%3D (Pubitemid 39362040)
31. Jonkman S, Risbrough VB, Geyer MA, Markou A (2008) Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 33:2131-2138 (Pubitemid 351992083)
32. M Kalinichev SG Holtzman 2003 Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence J Pharmacol Exp Ther 304 603 609 12538812 10.1124/jpet.102.044206 1:CAS:528:DC%2BD3sXpvVCgug%3D%3D (Pubitemid 36152335)
33. PW Kalivas C O'Brien 2008 Drug addiction as a pathology of staged neuroplasticity Neuropsychopharmacology 33 166 180 17805308 10.1038/sj.npp. 1301564 1:CAS:528:DC%2BD2sXhtlKltbzM (Pubitemid 350191316)
34. JA Kim KA Pollak GO Hjelmstad HL Fields 2004 A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism Proc Natl Acad Sci USA 101 5664 5669 15064402 10.1073/pnas.0401373101 1:CAS:528:DC%2BD2cXjsVans74%3D (Pubitemid 38481213)
35. GF Koob M Le Moal 2008 Addiction and the brain antireward system Annu Rev Psychol 59 29 53 18154498 10.1146/annurev.psych.59.103006.093548
36. GF Koob R Maldonado L Stinus 1992 Neural substrates of opiate withdrawal Trends Neurosci 15 186 191 1377426 10.1016/0166-2236(92)90171-4 1:CAS:528:DyaK38XktF2lu7Y%3D
37. JH Krystal E Webb C Grillon N Cooney L Casal CA Morgan 3rd SM Southwick M Davis DS Charney 1997 Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP) Psychopharmacol (Berl) 131 207 215 10.1007/s002130050285 1:CAS:528:DyaK2sXktVGjtLc%3D (Pubitemid 27283581)
38. BB Land MR Bruchas JC Lemos M Xu EJ Melief C Chavkin 2008 The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J Neurosci 28 407 414 18184783 10.1523/JNEUROSCI.4458-07.2008 1:CAS:528:DC%2BD1cXovVGisQ%3D%3D
39. J Liu G Schulteis 2004 Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence Pharmacol Biochem Behav 79 101 108 15388289 10.1016/j.pbb.2004.06.006 1:CAS:528: DC%2BD2cXnvFahtL4%3D (Pubitemid 39237708)
40. WR Martin DR Jasinski 1969 Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence J Psychiatr Res 7 9 17 5352850 10.1016/0022-3956(69)90007-7 1:STN:280: DyaE3c%2FjslKmsQ%3D%3D
41. KB Mullis DC Perry AM Finn B Stafford W Sadee 1979 Morphine persistence in rat brain and serum after single doses J Pharmacol Exp Ther 208 228 231 762653 1:CAS:528:DyaE1MXltVWkt7g%3D (Pubitemid 9191711)
42. KM Myers WA Carlezon Jr 2009 D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats Biol Psychiatry 67 85 87 10.1016/j.biopsych.2009.08.015
43. JG Nutt DR Jasinski 1974 Methadone-naloxone mixtures for use in methadone maintenance programs I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence. Clin Pharmacol Ther 15 156 166 4812153 1:CAS:528:DyaE2cXksFynsL4%3D
44. I Nylander M Vlaskovska L Terenius 1995 The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats Psychopharmacol (Berl) 118 391 400 10.1007/BF02245939 1:CAS:528:DyaK2MXmtVensbs%3D
45. MF Olive M Bertolucci CJ Evans NT Maidment 1995 Microdialysis reveals a morphine-induced increase in pallidal opioid peptide release Neuroreport 6 1093 1096 7662884 10.1097/00001756-199505300-00005 1:CAS:528:DyaK2MXmslyntb8%3D
46. LA Parker A Joshi 1998 Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine Pharmacol Biochem Behav 61 331 333 9768568 10.1016/S0091-3057(98)00104-X 1:CAS:528: DyaK1cXmsVGks7k%3D (Pubitemid 28498216)
47. LA Parker JA Cyr AN Santi PD Burton 2002 The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning Pharmacol Biochem Behav 72 87 92 11900773 10.1016/S0091-3057(01)00724-9 1:CAS:528:DC%2BD38XitFWlt70%3D (Pubitemid 34251312)
48. TE Robinson KC Berridge 2003 Addiction Annu Rev Psychol 54 25 53 12185211 10.1146/annurev.psych.54.101601.145237 (Pubitemid 37417487)
49. GC Rosenfeld TF Burks 1977 Single-dose tolerance to morphine hypothermia in the rat: differentiation of acute from long-term tolerance J Pharmacol Exp Ther 202 654 659 197229 1:CAS:528:DyaE2sXlslOlurk%3D (Pubitemid 8170560)
50. PE Rothwell MJ Thomas JC Gewirtz 2009 Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure Neuropsychopharmacology 34 2285 2295 19494807 10.1038/npp.2009.56 1:CAS:528:DC%2BD1MXpvFygtr8%3D
51. PE Rothwell JC Gewirtz MJ Thomas 2010 Episodic withdrawal promotes psychomotor sensitization to morphine Neuropsychopharmacology 35 2579 2589 20811341 10.1038/npp.2010.134 1:CAS:528:DC%2BC3cXhsVWmsbbE
52. D Rylkova HP Shah E Small AW Bruijnzeel 2009 Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats Psychopharmacol (Berl) 203 629 640 10.1007/s00213-008-1409-z 1:CAS:528:DC%2BD1cXhsVeqs7zK
53. D Saal Y Dong A Bonci RC Malenka 2003 Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons Neuron 37 577 582 12597856 10.1016/S0896-6273(03)00021-7 1:CAS:528:DC%2BD3sXhvFelt70%3D (Pubitemid 36262980)
54. W Sadee D Wang EJ Bilsky 2005 Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities Life Sci 76 1427 1437 15680308 10.1016/j.lfs.2004.10.024 1:CAS:528:DC%2BD2MXntVSlsA%3D%3D (Pubitemid 40164772)
55. LL Sahuque EF Kullberg AJ McGeehan JR Kinder MP Hicks MG Blanton PH Janak MF Olive 2006 Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes Psychopharmacol (Berl) 186 122 132 10.1007/s00213-006-0362-y 1:CAS:528:DC%2BD28XjslGitrY%3D (Pubitemid 43668318)
56. SL Satel TR Kosten MA Schuckit MW Fischman 1993 Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry 150 695 704 8097618 1:STN:280:DyaK3s3ktlCmsg%3D%3D (Pubitemid 23137673)
57. G Schulteis A Markou LH Gold L Stinus GF Koob 1994 Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis J Pharmacol Exp Ther 271 1391 1398 7996451 1:STN:280:DyaK2M%2FovV2hsQ%3D%3D (Pubitemid 24382650)
58. RE See RP Waters 2010 Pharmacologically-induced stress: a cross-species probe for translational research in drug addiction and relapse Am J Transl Res 3 81 89 21139808
59. JR Shoblock NT Maidment 2006 Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice Neuropsychopharmacology 31 171 177 15956992 1:CAS:528:DC%2BD2MXhtlWjsrzF (Pubitemid 43250952)
60. JR Shoblock NT Maidment 2007 Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal Neuroscience 149 642 649 17905519 10.1016/j.neuroscience.2007.05.011 1:CAS:528:DC%2BD2sXht1ahu7nL (Pubitemid 47633015)
61. RJ Smith G Aston-Jones 2008 Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence Brain Struct Funct 213 43 61 18651175 10.1007/s00429-008-0191-3
62. SM Stine CG Grillon CA Morgan 3rd TR Kosten DS Charney JH Krystal 2001 Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine Psychopharmacol (Berl) 154 274 281 10.1007/s002130000644 1:CAS:528:DC%2BD3MXjsVens7k%3D (Pubitemid 32247188)
63. SM Stine SM Southwick IL Petrakis TR Kosten DS Charney JH Krystal 2002 Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients Biol Psychiatry 51 642 651 11955464 10.1016/S0006-3223(01)01292-6 1:CAS:528:DC%2BD38XivVaju7w%3D (Pubitemid 34310501)
64. L Stinus S Caille GF Koob 2000 Opiate withdrawal-induced place aversion lasts for up to 16 weeks Psychopharmacol (Berl) 149 115 120 10.1007/ s002139900358 1:CAS:528:DC%2BD3cXjtFWntb0%3D (Pubitemid 30238948)
65. TM Tzschentke 1998 Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues Prog Neurobiol 56 613 672 9871940 10.1016/S0301-0082(98)00060-4 1:CAS:528:DyaK1MXitVSqsQ%3D%3D (Pubitemid 29012461)
66. TM Tzschentke 2007 Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict Biol 12 227 462 17678505 10.1111/j.1369-1600.2007.00070.x 1:CAS:528:DC%2BD2sXhtFGgsLrE (Pubitemid 47196347)
67. MA Ungless JL Whistler RC Malenka A Bonci 2001 Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons Nature 411 583 587 11385572 10.1038/35079077 1:CAS:528:DC%2BD3MXksVShsr4%3D (Pubitemid 32531404)
68. GR Valdez AJ Roberts K Chan H Davis M Brennan EP Zorrilla GF Koob 2002 Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin- releasing factor Alcohol Clin Exp Res 26 1494 1501 12394282 10.1111/j.1530-0277. 2002.tb02448.x 1:CAS:528:DC%2BD38XotVCmt70%3D (Pubitemid 35192310)
69. LJ Vanderschuren ED Schmidt TJ De Vries CA Van Moorsel FJ Tilders AN Schoffelmeer 1999 A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats J Neurosci 19 9579 9586 10531460 1:CAS:528:DyaK1MXnslyhs78%3D (Pubitemid 30228109)
70. LJ Vanderschuren TJ De Vries G Wardeh FA Hogenboom AN Schoffelmeer 2001 A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats Eur J Neurosci 14 1533 1538 11722615 10.1046/j.0953-816x. 2001.01775.x 1:STN:280:DC%2BD3Mnns12mtQ%3D%3D (Pubitemid 35463720)
71. DL Walker M Davis 2002 Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety Psychopharmacol (Berl) 164 318 328 10.1007/s00213-002-1213-0 1:CAS:528:DC%2BD38XosFWgt7g%3D (Pubitemid 35340999)
72. D White-Gbadebo SG Holtzman 1994 Acute sensitization to opioid antagonists Pharmacol Biochem Behav 47 559 566 8208774 10.1016/0091-3057(94) 90159-7 1:CAS:528:DyaK2cXhvVaqt74%3D (Pubitemid 24077725)
73. Z Zhang G Schulteis 2008 Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze Pharmacol Biochem Behav 89 392 403 18308382 10.1016/j.pbb.2008.01.013 1:CAS:528:DC%2BD1cXjs1WnsLs%3D
74. Y Zhao F Weiss EP Zorrilla 2007 Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats Alcohol Clin Exp Res 31 1505 1515 17760785 10.1111/j.1530-0277.2007.00456.x (Pubitemid 47319664)